Syngenta Group expects the crop protection market to stabilize this year after it posted a decline in sales and profit during ...

Results from Phase 2a Trial demonstrate a good safety and tolerability profile of VXM01 and Avelumab Combination Therapy in ...

Five experts – curators, programmers, artists and academics – debate the changing role and visibility of artists’ moving ...